Dr. Nicholas Fleischer is a Vice President at The Weinberg Group. He has 36 years of experience in biopharmaceutics, pharmacokinetics, pharmacy and clinical pharmacology. Prior to joining The Weinberg Group, Dr. Fleischer held several positions at the United States Food and Drug Administration (FDA), the most recent being Director of the Division of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and Research (CDER). Prior to joining the FDA, Dr. Fleischer was Deputy Chief, Assistant Chief, and Director of Quality Control in the Pharmacy Department of the United States Public Health Service Hospital, Staten Island, New York. He received his Ph.D. in Pharmacology from the Uniformed Services University of the Health Sciences, a M.S. in Hospital Pharmacy Administration from the Long Island University, and a B.S. in Pharmacy from the Massachusetts College of Pharmacy.